Skip to main content
SpringerLink
Log in
Book cover

In Pursuit of Nanoethics pp 131–145Cite as

The Risks of Nanomedicine and the Precautionary Principle

  • Chapter
  • First Online:

Part of the book series: The International Library of Ethics, Law and Technology ((ELTE,volume 10))

Abstract

In a famous passage of his Pensées which aims to emphasize the need for humility about our limited capacities, Pascal calls the attention to the fact that we as human beings are engulfed between two infinite spaces, the infinitely great of the cosmos and the infinitely small of the microcosmic world. And he adds: “The eternal silence of these infinite spaces frightens me” (“Le silence éternel de ces espaces infinis m’effraie”) (n° 187).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Andorno, R. 2004a. The right not to know: An autonomy based approach. Journal of Medical Ethics 30: 435–440.

    Article  Google Scholar 

  • Andorno, R. 2004b. The precautionary principle: A new legal standard for a technological age. Journal of International Biotechnology Law 1(1): 11–19.

    Article  Google Scholar 

  • Bachmann, A. 2006. Nanobiotechnologie. Eine ethische Auslegeordnung, Bern, EKAH (Eidgnenossische Ethikkommission für die Biotechnologie im Ausserhumanbereich).

    Google Scholar 

  • Balbus, J., R. Denison, K. Florini, and S. Walsh. 2005. Getting nanotechnology right the first time. Issues in Science and Technology, Summer, 65–71. Available online at: http://www.issues.org/issues/21.4/balbus.html.

  • Balbus, J., et al. 2007. Meeting report: Hazard assessment for nanoparticles. Report from an interdisciplinary workshop. Environmental Health Perspectives 115(11): 1654–1659.

    Article  Google Scholar 

  • Bawa, R., and S. Johnson. 2007. The ethical dimensions of nanomedicine. Medical Clinics of North America 91(5): 881–887.

    Article  Google Scholar 

  • Borm, P., et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Particle and Fibre Toxicology 3(11): 1–35. Available online at: http://www.particleandfibretoxicology.com/content/3/1/11.

  • Capurro, R. 2006. Reflections on the ethical aspects of nanomedicine. At: http://www.capurro.de/nanoethics.html.

  • CCNE (Comité Consultatif National d’Ethique). 2007. Opinion n° 96: Ethical issues raised by nanosciences, nanotechnologies and health, Paris. Available online at: http://www.comite-ethique.fr/opinions.php.

  • Coalition of international NGOs. 2007. Principles for the oversight of nanotechnologies and nanomaterials. Online available at: http://www.etcgroup.org/upload/publication/pdf_file2/651.

  • COMEST (UNESCO’s World Commission on the Ethics of Scientific Knowledge and Technology). 2005. The precautionary principle. Paris: UNESCO.

    Google Scholar 

  • Duffin, R., A. Clouter, D.M. Brown, C.L. Tran, W. MacNee, V. Stone, and K. Donaldson. 2002. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Annals of Occupational Hygiene 46(Suppl. 1): 242–245.

    Article  Google Scholar 

  • ECJ (European Court of Justice). 1998. Case C-180/96, United Kingdom v. Commission of the European Communities, 5 May 1998, ECR 1998, I-2265.

    Google Scholar 

  • EGE (European Group on Ethics in Science and New Technologies). 2007. Opinion on the ethical aspects of nanomedicine (Opinion n° 21). Brussels: European Commission. Available online at: http://ec.europa.eu/european_group_ethics/activities/docs/opinion_21_nano_en.pdf.

  • ETC Group. 2003. From genomes to atoms. The big down. Atomtech: Technologies converging at the nano-scale. Winnipeg: ETC Group. Available online at: http://www.etcgroup.org/upload/publication/171/01/thebigdown.pdf.

  • ETC Group. 2006. Nanotech Rx – Medical applications of nano-scale technologies: What impact on marginalized communities? Ottawa: ETC Group. Available online at: http://www.etcgroup.org/en/materials/publications.html?pub_id=593.

  • European Commission. 2000. Communication on the precautionary principle, 2 February 2000.

    Google Scholar 

  • European Council. 2000. Resolution on the precautionary principle. Annex III to the Presidency Conclusions of the Nice European Council Meeting, 7–9 December 2000.

    Google Scholar 

  • Faunce, T., and K. Shats. 2007. Researching safety and cost-effectiveness in the life cycle of nanomedicine. Journal of Law and Medicine 15: 128–134.

    Google Scholar 

  • Freitas, Jr. R.A. 1999. Nanomedicine. Volume I: Basic capabilities. Georgetown: Landes Bioscience. Available online at: http://www.nanomedicine.com/NMI.htm.

  • Gordijn, B. 2007. Ethical issues in nanomedicine. In Nanotechnologies, ethics and politics, ed. H. ten Have, 99–123. Paris: UNESCO.

    Google Scholar 

  • Hett, A., et al. 2004. Nanotechnology – Small matter, many unknowns (Report). Zurich: Swiss Reinsurance Company (“SwissRe”).

    Google Scholar 

  • Hook, C.C. 2004. Nanotechnology. In Encyclopedia of bioethics, vol. 4, 3rd ed, ed. S. Post, 1871–1875. New York: MacMillan.

    Google Scholar 

  • Hook, C.C. 2007. Nanotechnology and the future of medicine. In Nanoscale: Issues and perspectives for the nano century, ed. N.M. de S. Cameron and M.E. Mitchell, 337–357. Hoboken: Wiley-Interscience.

    Google Scholar 

  • Kenny, L. 2007. The risk governance of nanotechnology: Recommendations for managing a global issue. Zurich: Swiss Reinsurance Company (Swiss Re), Centre for Global Dialogue.

    Google Scholar 

  • Lenk, C., and N. Biller-Andorno. 2007. Nanomedicine–emerging or re-emerging ethical issues? A discussion of four ethical themes. Medicine Health Care and Philosophy 10(2): 173–184.

    Article  Google Scholar 

  • Oberdörster, E. 2004. Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environmental Health Perspectives 112(10): 1058–1062.

    Google Scholar 

  • Phoenix, C., and M. Treder. 2003. Applying the precautionary principle to nanotechnology. Brooklyn: Center for Responsible Nanotechnology (CRN). Available online at: http://crnano.org/precautionary.htm.

  • Saunders, P. 2000. Use and abuse of the precautionary principle, Institute of Science in Society (ISIS) submission to US Advisory Committee on International Economic Policy. Available online at: http://www.i-sis.org.uk/prec.php.

  • SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials. Brussels: European Commission. Available online at: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_004c.pdf.

  • Schmid, G., et al. 2006. Nanotechnology: Assessment and perspectives. Berlin: Springer.

    Google Scholar 

  • Stebbing, M. 2009. Avoiding the trust deficit: Public engagement, values, the precautionary principle and the future of nanotechnology. Bioethical Inquiry 6: 37–48.

    Article  Google Scholar 

  • UK-ILGRA (Interdepartmental Liaison Group on Risk Assessment). 2002. The precautionary principe: Policy and application, London. Available online at: http://www.hse.gov.uk/aboutus/meetings/ilgra/pppa.htm.

  • UK-RSRAE (Royal Society and the Royal Academy of Engineering). 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties, summary and recommendations. London: Royal Society. Available online at: http://www.nanotec.org.uk/finalReport.htm.

  • Zhao, X., A. Striolo, and P. Cummings. 2005. C60 binds to and deforms nucleotides. Biophysical Journal 89: 3856–3862.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Law, University of Zurich, Zurich, Switzerland

    Roberto Andorno

  2. Institute of Biomedical Ethics, University of Zurich, Zurich, Switzerland

    Nikola Biller-Andorno

Authors
  1. Roberto Andorno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikola Biller-Andorno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Andorno .

Editor information

Editors and Affiliations

  1. Dublin City University, Dublin 9, Ireland

    Bert Gordijn

  2. University of Central Lancashire, Preston, United Kingdom

    Anthony Mark Cutter

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Andorno, R., Biller-Andorno, N. (2014). The Risks of Nanomedicine and the Precautionary Principle. In: Gordijn, B., Cutter, A. (eds) In Pursuit of Nanoethics. The International Library of Ethics, Law and Technology, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6817-1_9

Download citation

Publish with us

Policies and ethics

Search

Navigation